A Phase IIA Trial of Empagliflozin and Intranasal Insulin for MCI/AD

Project Number
PTC-22-975243
Agency/Funding Organization
Alzheimer's Association
Funding Year
2022
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
SUZANNE
Principal Investigator Last Name
CRAFT
Awardee State
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$795,850
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official